ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.465,69
0,00%
S&P 500
5.180,74
1,03%
US Dollar vs BRL
5,07628
0,00%
Bitcoin
63.557,21
0,62%
Brent Oil
82,965
-0,61%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. AMEX
  6. Aoxing Pharmaceutical Company New (delisted) (AXN)

  7. Aoxing Pharmaceutical Company New (delisted) (AXN) Notícias

AXN

Aoxing Pharmaceutical Company New (delisted) (AXN)

Aoxing Pharmaceutical Company New (delisted)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:AMEX:AXN
DataHoraFonteTítuloCódigoCompanhia
17/10/201715:28Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
06/10/201717:17Edgar (US Regulatory)(25)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
06/10/201707:03Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
29/09/201707:04Edgar (US Regulatory)Withdrawal of Registration Statement (ammendment) (aw)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
28/09/201707:04Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
27/09/201716:10Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
26/09/201712:03Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
25/09/201707:02Edgar (US Regulatory)Current Report Filing (8-k)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
15/05/201709:39Edgar (US Regulatory)Quarterly Report (10-q)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
11/05/201711:21Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
11/05/201711:20Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
17/02/201715:34Edgar (US Regulatory)Amended Quarterly Report (10-q/a)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
05/10/201617:33Edgar (US Regulatory)Annual Report (10-k)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
08/02/201611:30PR Newswire (US)Aoxing Pharmaceuticals Q2 Revenue Up 27%; Net Income $2.1 Million, Up 265%AMEX:AXNAoxing Pharmaceutical Company New (delisted)
01/02/201611:30PR Newswire (US)Aoxing Pharma Appoints Dr. James Chen as Chief Financial OfficerAMEX:AXNAoxing Pharmaceutical Company New (delisted)
10/12/201511:30PR Newswire (US)Aoxing Pharma Selected to Supply Zhongtongan to the Insurance System for the City of ShanghaiAMEX:AXNAoxing Pharmaceutical Company New (delisted)
04/12/201511:30PR Newswire (US)Aoxing Pharma Announces Opening Of Government Funded Drug Research CenterAMEX:AXNAoxing Pharmaceutical Company New (delisted)
04/12/201511:00PR Newswire (US)Aoxing Pharma Announces Resignation of CFOAMEX:AXNAoxing Pharmaceutical Company New (delisted)
03/12/201513:38PR Newswire (US)SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Aoxing Pharmaceutical Company, Inc.AMEX:AXNAoxing Pharmaceutical Company New (delisted)
02/12/201521:27PR Newswire (US)SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aoxing Pharmaceutical, Inc. - AXNAMEX:AXNAoxing Pharmaceutical Company New (delisted)
13/11/201511:30PR Newswire (US)Aoxing Pharmaceuticals Q1 Revenue Up 92 Percent; Net Income Of $1.35 MillionAMEX:AXNAoxing Pharmaceutical Company New (delisted)
28/09/201517:14Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
28/07/201510:10PR Newswire (US)Drug Manufacturers - Major Stocks on the Move -- GlaxoSmithKline, Sanofi, Aerie Pharma, TherapeuticsMD, and Aoxing PharmaAMEX:AXNAoxing Pharmaceutical Company New (delisted)
22/06/201518:15Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
09/02/201517:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
09/02/201516:58Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
16/06/201421:26MarketwiredAoxing Pharmaceutical Company, Inc. Receives Notice of Extension From NYSEMKT LLCAMEX:AXNAoxing Pharmaceutical Company New (delisted)
14/05/201418:45MarketwiredAoxing Pharmaceutical Company, Inc. Announces Financial Results for Third Quarter of 2014 Fiscal YearAMEX:AXNAoxing Pharmaceutical Company New (delisted)
04/03/201419:30MarketwiredAoxing Pharmaceutical Company, Inc. Receives Notice of Extension and Additional Notice of Noncompliance From NYSEMKT LLCAMEX:AXNAoxing Pharmaceutical Company New (delisted)
19/02/201414:15MarketwiredAoxing Pharmaceutical Company, Inc. Announces Financial Results for Second Quarter of 2014 Fiscal YearAMEX:AXNAoxing Pharmaceutical Company New (delisted)
 Apresentando as notícias mais relevantes sobre:AMEX:AXN

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
BHIA3
Grupo Casas Bahia ON
BOV
PRIO3
PETRORIO ON
BOV
MNPR3
MINUPAR ON
BOV
NGRD3
Neogrid Participacoes ON
BOV
TELB4
TELEBRAS PN
BOV
HOOT4
HOTEIS OTHON PN
BOV
ENAT3
ENAUTA ON
BOV
COGN3
COGNA ON
BOV
LIGT3
LIGHT ON
BOV
GOLL4
GOL PN
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados